IVF Cost and Insurance in India: What the Law Actually Says

Usually not. IRDAI does not mandate that health insurance providers include IVF or any assisted reproductive procedure in standard policies, and most plans exclude infertility treatment explicitly.

That exclusion applies across individual policies, family floater plans and employer-sponsored group cover. It is written into the policy wording rather than being a matter of interpretation at claim time.

• IRDAI does not require insurers to cover IVF.
• Most policies list infertility treatment as an exclusion.
• A 2019 IRDAI circular encouraged reconsideration — it did not compel it.
• Some employers add fertility benefits voluntarily; check the policy, not the rumour.

The practical step is to read the exclusions section of your own policy document rather than asking generally whether IVF is covered. The answer is in the wording, and it is usually unambiguous.

Parts of the pathway that are not the assisted reproduction itself. Investigation of an underlying condition, and treatment of that condition, may sit outside the infertility exclusion depending on how the policy is worded.

• Diagnostic investigation of an underlying gynecological condition.
• Surgery for a condition such as fibroids or endometriosis.
• Complications requiring admission, including OHSS in some policies.
• None of this is guaranteed — the wording decides.

Ask the insurer in writing before treatment rather than after. A verbal assurance from a call center is not a basis for a claim, and pre-authorisation is where these questions get settled.

Our article on OHSS and stimulation side effects covers the complication most likely to involve an unplanned admission.

• ICSI: A Breakthrough in Fertility Treatment
• Managing Finances for Fertility Treatments
• Sperm Donation: Myths and Facts You Need to Know
• Egg Freezing: Preserving Fertility for Your Future
• Insurance and Fertility: What Couples Need to Know
• The Role of Sperm Donation in Modern Fertility Treatments

The clinic, not the price. The ART (Regulation) Act 2021 and the Surrogacy (Regulation) Act 2021 both took effect on 25 January 2022, and together they govern every IVF clinic, ART bank and donor program in India.

Registration is compulsory. Clinics and banks must apply to the National ART and Surrogacy Registry to operate legally, and are classified as Level 1, covering intrauterine insemination only, or Level 2, covering IVF and research.

• Clinic registration with the National Registry is compulsory.
• Level 1 clinics may perform IUI only; Level 2 covers IVF.
• Donor screening standards are set in law.
• Written patient consent is mandated.

The Act also fixes eligibility by age: the woman must be between 21 and 50, and the man between 21 and 55. Those are legal limits rather than clinical recommendations, and a clinic cannot waive them.

Registration first, then what the quoted figure actually includes. Fertility treatment is quoted in ways that make comparison difficult, and the gap between a headline price and a final bill is usually made of things that were always going to be needed.

• Confirm the clinic's registration and level under the ART Act.
• Ask whether medication is included — it rarely is, and it is substantial.
• Ask what a canceled cycle costs, and what is refundable.
• Ask whether freezing, storage and later transfer are extra.

Add-ons deserve their own question. Our article on PGT-A covers the most heavily marketed one, where ASRM's position is that its value as routine screening has not been demonstrated — an expense worth understanding before agreeing to it.

Because so much of the cost sits outside the quoted cycle fee, the useful question is not what a cycle costs but what a course of treatment costs, including the likelihood of needing more than one.

If you are gathering quotes in one city, it is worth seeing what each clinic publishes before you ask. Our Bangalore fertility clinic directory records what each one discloses about pricing and outcomes, and where the record is silent.

Cost is where fertility marketing is least constrained, and several common claims should be treated sceptically.

• A higher price does not indicate a better clinic.
• Package deals may exclude the items most likely to be needed.
• A high advertised success rate may reflect patient selection, not skill.
• No add-on has been shown to raise live birth rates as routine treatment.

Our article on reading success rates covers why quoted percentages are so hard to compare, and what to ask so that two clinics' figures mean the same thing.

One structural point about cost is worth stating, because it is rarely said. Most of the expense of fertility treatment falls on people at the point where they have least capacity to negotiate — mid-treatment, invested, and told a further step is advisable. Deciding in advance what you are prepared to spend, across how many cycles, is the only real protection against that.

Government schemes and hospital-level subsidies exist in some states and institutions, and their availability changes. It is worth asking directly rather than assuming private payment is the only route.